Treatment outcome in patients with HCV Genotype-3a Infection, Treated with 24-Weeks Dual Therapy (Sofosbuvir and Ribavirin). Medical Forum Monthly, [S. l.], v. 28, n. 11, 2024. Disponível em: https://medicalforummonthly.com/index.php/mfm/article/view/4275.. Acesso em: 25 sep. 2025.